Status:
UNKNOWN
Efficacy and Safety of Topical Methotrexate Gel 1% Coupled With Microneedling in Treatment of Warts
Lead Sponsor:
Assiut University
Conditions:
Warts
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
To study the clinical efficacy of the topically applied MTX hydrogel preparation combined with microneedling to increase drug delivery and efficacy in comparison with cryotherapy in treatment of warts...
Detailed Description
Warts are benign proliferation of skin and mucosa caused by the human papilloma virus (HPV). Currently, over 170 HPV types have been identified. Certain HPV types tend to infect skin at anatomical sit...
Eligibility Criteria
Inclusion
- Patients older than 18 years up to 60 years old.
- Patients with plantar or common warts.
Exclusion
- pregnancy and lactation
- immunosuppression or being under any kind of treatment causing absolute or relative immunosuppression.
- history of any bleeding, clotting disorder or using anticoagulants.
- chronic systemic diseases such as chronic renal failure, hepatic insufficiency, and cardiovascular disorders.
- concurrent use of systemic or topical treatments of warts .
Key Trial Info
Start Date :
June 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2023
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT05300009
Start Date
June 15 2022
End Date
August 15 2023
Last Update
March 29 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.